For press and media inquiries, please contact us at email@example.com.
MS Pen Technologies, Inc. is a biotech company developing real-time tissue diagnostics to optimize medical decisions, surgical interventions, and treatment options for patients. The company’s debut technology is the MasSpec Pen System™, a bespoke mass spectrometry diagnostic platform capable of characterizing cancerous tissue — both in vivo and ex vivo — in just 10 seconds. The technology will save patients, surgeons, and hospital systems complications and financial burden.
Justin Wiseman, Ph.D.
Livia Schiavinato Eberlin, Ph.D.
Co-Founder, Chief Scientific Officer
James W. Suliburk, M.D.
Co-Founder, Chief Medical Officer
Thomas E. Milner, Ph.D.
Co-Founder, Technology Advisor
If you are interested in learning more about MS Pen Technologies, our diagnostic platform, or investment and partnership opportunities, please feel free to reach out.